Previous Page  14 / 15 Next Page
Information
Show Menu
Previous Page 14 / 15 Next Page
Page Background

Page 60

Notes:

conferenceseries

.com

Volume 8

Medicinal Chemistry

ISSN: 2161-0444

Medicinal Chemistry 2018

June 14-15, 2018

June 14-15, 2018 | Barcelona, Spain

10

th

World Congress on

Medicinal Chemistry and Drug Design

Development of 3, 5-dinitrophenyl containing heterocycles: Structure-antimycobacterial activity

relationships studies

Galina Karabanovich

Charles University, Czech Republic

O

ur research focuses on the design and synthesis of novel nitro group containing heterocyclic compounds with high and

selective antimycobacterial efficiency and on the study of relationships between their structure and antimycobacterial

activities/toxicities. Previously described 1-alkyl-5-(3,5-dinitrobenzyl)sulfanyl-1H-tetrazoles and 2-alkyl-5-(3,5-dinitrobenzyl)

sulfanyl-1,3,4-oxadiazoles showed outstanding activities against drug-susceptible and drug-resistant strains of

Mycobacterium

tuberculosis (M. tuberculosis.).

Their minimum inhibitory concentrations reached 0.5 μm and 0.03 μm, respectively.

Moreover, 1, 3, 4-oxadiazole derivatives were active against replicating and nonreplicating strains of

z

. Described compounds

demonstrated selective effect on mycobacteria as were inactive against tested fungi and bacteria and exhibited low

in vitro

genotoxicity and toxicity in mammalian cell lines. Current work continues to study the role of individual fragments of

previously described molecules in their biological properties. We focused on influence of the heterocycle and Benzylsulfonyl

linker on antimycobacterial activity. Results of

in vitro

evaluation showed that both fragments play a significant role in the

antimycobacterial efficacy of target compounds. Moreover, alkyl/aryl substituents on heterocycle could also affect compounds

efficacy.

Biography

Galina Karabanovich has completed her PhD at the Faculty of Pharmacy in Hradec Kralove, Charles University. Currently, she occupies the Postdoctoral position at

the same University. She has published 12 papers, majority of them in medicinal chemistry journals. Her research interests are focused on the design and synthesis

of compounds with potential antimycobacterial activity; study of the relationships between structure and antimycobacterial activity of prepared substances; synthesis

of dexrazoxane analogues.

karabang@faf.cuni.cz

Galina Karabanovich, Med chem (Los Angeles) 2018, Volume 8

DOI: 10.4172/2161-0444-C1-039